510(k) K082905

MEDRAD STELLANT CT INJECTOR SYSTEM WITH P3T CARDIAC by Medrad, Inc. — Product Code DXT

K082905 is an FDA 510(k) premarket notification submitted by Medrad, Inc. for the device "MEDRAD STELLANT CT INJECTOR SYSTEM WITH P3T CARDIAC". The FDA issued a decision of Substantially Equivalent on January 12, 2009. The device falls under product code DXT (Injector And Syringe, Angiographic), a Class II device regulated under 21 CFR 870.1650. Medrad, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
January 12, 2009
Date Received
September 30, 2008
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Injector And Syringe, Angiographic
Device Class
Class II
Regulation Number
870.1650
Review Panel
HO
Submission Type